US Patent Issued to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, OHIO STATE UNIVERSITY on July 8 for "Identification of HER2 mutations in lung cancer and methods of treatment" (Arizona, Ohio Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,878, issued on July 8, was assigned to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (Phoenix) and OHIO STATE UNIVERSITY (Columbus, Ohio).

"Identification of HER2 mutations in lung cancer and methods of treatment" was invented by William Hendricks (Phoenix), Muhammed Murtaza (Phoenix) and Gwendolen Lorch (Columbus, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for treating lung cancer, and more particularly for treating pulmonary adenocarcinoma in a canine subject. The method may comprise assaying a biological sample from the canine subject, such as a tumor sample or a plasma sample, for a mutation in the HER2 gene. The mut...